Differential in vitro and in vivo antitumor effects mediated by anti-CD40 and anti-CD20 monoclonal antibodies against human B-cell lymphomas

Journal of Immunotherapy

Volumn 19, Issue 2, 1996, Pages 93-101

  Funakoshi, Satoshi ^a   Longo, Dan L ^a   Murphy, William J ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

Anti CD20; Anti CD40; B Lymphoma; Human mouse; Immunotherapy

Indexed keywords

CD20 ANTIGEN; CD40 ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; B CELL LYMPHOMA; CANCER IMMUNOTHERAPY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029981846     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-199603000-00002     Document Type: Article

References (18)

1. Durandy A, Brousse N, Rozenberg F, De Saint Basaile G, Fischer AM, Fischer A. Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies. J Clin Invest 1992;90:945-52.
2. Press OW, Appelbaum F, Ledbetter JA, et al. Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas. Blood 1987;69:584-91.
3. Shah SA, Halloran PM, Ferris CA, et al. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models. Cancer Res 1993;53:1360-7.
4. Nonoyama S, Hollenbaugh D, Aruffo A, Ledbetter JA, Ochs HD. B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J Exp Med 1993;178:1097-1102.
5. Splawski JB, Fu SM, Lipsky PE. Immunoregulatory role of CD40 in human B cell differentiation. J Immunol 1993;150: 1276-85.
6. Funakoshi S, Longo DL, Beckwith M, et al. Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood 1994;83:2787-94.
7. Clark EA, Shu G, Ledbetter JA. Role of the Bp35 cell surface polypeptide in human B-cell activation. Proc Natl Acad Sci USA 1985;82:1766-70.
8. Unkeless JC. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 1979;150:580-96.
9. Araujo-Jorge T, Rivera MT, Bouhdidi AE, Daeron M, Carlier Y. An FcγRII-, FcγRIII-specific monoclonal antibody (2.4G2) decrease acute Trypanosoma cruzi infection in mice. Infect Immun 1993;61:4925-8.
10. Beckwith M, Longo DL, O'Connell CD, Moratz CM, Urba WJ. Phorbol ester-induced, cell-cycle-specific, growth inhibition of human B-lymphoma cell lines. J Natl Cancer Inst 1990;82:501-9.
11. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988;335:256-9.
12. Pulvertaft RJV. Cytology of Burkitt's tumor (African lymphoma). Lancet 1964;11:238-40.
13. Murphy WJ, Bennett M, Anver MR, Baseler M, Longo DL. Human-mouse lymphoid chimeras: host-vs.-graft and graft-vs.-host reactions. Eur J Immunol 1992;22:1421-7.
14. Holder MJ, Wang H, Milner AE, et al. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur J Immunol 1993;23:2368-71.
15. Gamier J-L, Cooper NR, Cannon MJ. Low expression of CD20 and CD23 in Epstein-Barr virus-induced B cell tumors in SCID/hu mice. Am J Pathol 1993;142:353-83.
16. Herlyn D, Herlyn M, Steplewski Z, Koprowski H. Monoclonal anti-human tumor antibodies of six isotypes in cytotoxic reactions with human and murine effector cells. Cell Immunol 1985;92:105-14.
17. Kawata A, Yoshida M, Okazaki M, Yokota S, Barcos M, Seon BK. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody. Cancer Res 1994;54:2688-94.
18. Herlyn D, Powe J, Ross AH, Herlyn M, Koprowski H. Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells. J Immunol 1985;134:1300-4.